Biosplice Therapeutics, Inc.

This study tested a drug called lorecivivint for people with knee osteoarthritis over two years. It included 276 adults who had already been in a previous study. The goal was to see if the drug could safely reduce pain and improve knee function. The trial was stopped early, so re…

This study tested an injection called lorecivivint for people with moderate to severe knee osteoarthritis. The goal was to see if it could improve cartilage health and reduce pain. Only 13 people took part, and the study was stopped early. It was not a cure, but aimed to control …

This study tested an experimental drug called lorecivivint, given as a shot into the knee, to see if it safely eases pain and improves function in people with knee osteoarthritis. The study planned to follow 72 adults aged 40 to 80 for up to 3 years, but it was stopped early. The…